Effect of WEGOVY Injection on Anthropometry and Cardiometabolic Parameters in Adults Changes in waist circumference and cardiometabolic parameters with WEGOVY injection are shown in Table 13 for Studies 2, 3, and 4
Don't Forget Lifestyle Factors Nutrition is important, but other habits also matter
These included isolated cases of pancreatitis, prolonged QT syndrome (associated with concomitant medications), and transient elevations in liver enzymes
Wegovy (semaglutide): 7% of adults taking the 2.4 mg dose, and 4% of pediatric patients 12 years and older taking the 2.4 mg dose
These therapies not only target weight loss but also address underlying metabolic and hormonal factors that contribute to obesity and aging
Available at: Sanchis-Gomar, F., Neeland, I.J